GB201221032D0 - Method of treatment - Google Patents
Method of treatmentInfo
- Publication number
- GB201221032D0 GB201221032D0 GBGB1221032.4A GB201221032A GB201221032D0 GB 201221032 D0 GB201221032 D0 GB 201221032D0 GB 201221032 A GB201221032 A GB 201221032A GB 201221032 D0 GB201221032 D0 GB 201221032D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1221032.4A GB201221032D0 (en) | 2012-11-22 | 2012-11-22 | Method of treatment |
PCT/GB2013/000508 WO2014080161A1 (en) | 2012-11-22 | 2013-11-21 | Vip and an alpha-adrenergic blocker for use in the treatment of erectile dysfunction post radical prostatectomy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1221032.4A GB201221032D0 (en) | 2012-11-22 | 2012-11-22 | Method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201221032D0 true GB201221032D0 (en) | 2013-01-09 |
Family
ID=47560499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1221032.4A Ceased GB201221032D0 (en) | 2012-11-22 | 2012-11-22 | Method of treatment |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201221032D0 (en) |
WO (1) | WO2014080161A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5447912A (en) * | 1989-09-18 | 1995-09-05 | Senetek, Plc | Erection-inducing methods and compositions |
US5236904A (en) * | 1989-09-18 | 1993-08-17 | Senetek, Plc | Erection-inducing methods and compositions |
AU749703B2 (en) * | 1997-05-19 | 2002-07-04 | Repros Therapeutics Inc. | Combination therapy for modulating the human sexual response |
AU2001281396A1 (en) * | 2000-08-08 | 2002-02-18 | The Trustees Of Boston University | Novel compositions and methods for treatment of male erectile dysfunction |
US20090123571A1 (en) * | 2005-03-25 | 2009-05-14 | Alan Meehan | Method of treating men with testosterone supplement and 5alpha-reductase inhibitor |
WO2007016361A2 (en) * | 2005-07-29 | 2007-02-08 | Concert Pharmaceuticals Inc. | Novel pharmaceutical compounds |
-
2012
- 2012-11-22 GB GBGB1221032.4A patent/GB201221032D0/en not_active Ceased
-
2013
- 2013-11-21 WO PCT/GB2013/000508 patent/WO2014080161A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014080161A1 (en) | 2014-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2773754A4 (en) | Method of treatment | |
GB201110095D0 (en) | Method of treatment | |
EP2723384A4 (en) | Treatment of proteinopathies | |
EP2717855A4 (en) | Methods of treatment | |
HK1210962A1 (en) | Methods for treatment of atherosclerosis | |
EP2895206A4 (en) | Method of treating cancer | |
HK1203370A1 (en) | Method for treatment of labor arrest | |
HK1216504A1 (en) | Method for treatment of diseases | |
EP2884975A4 (en) | Method of treating onychomycosis | |
IL241096A0 (en) | Method of treatment | |
EP2812338A4 (en) | Method of treatment of nasopharyngeal caner | |
GB201215942D0 (en) | Method of treatent | |
EP2791324A4 (en) | Method of treatment | |
GB201221032D0 (en) | Method of treatment | |
GB201207894D0 (en) | Method of treatment | |
GB201221118D0 (en) | Methods of treatment | |
GB201216748D0 (en) | Methods of treatment | |
GB201216740D0 (en) | Methods of treatment | |
GB201206324D0 (en) | Methods of treatment | |
GB201206325D0 (en) | Methods of treatment | |
GB201206326D0 (en) | Methods of treatment | |
GB201206330D0 (en) | Methods of treatment | |
EP2911662A4 (en) | Method of treatment of disease | |
GB201111530D0 (en) | Method of treatment | |
GB201109509D0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |